Clinical Trials Directory

Trials / Completed

CompletedNCT00086411

Comparing Smoking Treatment Programs for Lighter Smokers - 1

Comparing Smoking Treatment Programs for Lighter Smokers

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
260 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.

Detailed description

The study compared a minimal level counseling model to a higher level counseling model plus one of two types of FDA approved smoking cessation products (bupropion or the nicotine patch)used to achieve long term abstinence among lighter smokers. Each participant received both products under blinded conditions meaning that neither the participant nor the counselor knew which product was real or a placebo. The primary goal was to determine the combination or combinations of high or low intensity counseling and pharmacotherapy (either bupropion or the nicotine patch) that were most effective for lighter smokers. The main hypothesis was that higher level counseling would contribute to improved outcomes meaning that more counseling would be associated higher abstinence rates following the completion of treatment and at longer term follow-up.

Conditions

Interventions

TypeNameDescription
DRUGnicotine transdermal systemstarting with 21 or 14mg dependent on number of cigarettes per day smoked upon entry in the study; titrated down over 8 weeks.
DRUGbupropion150 mg/day X 3 days 300mg/day for 60 days Total 9 weeks
BEHAVIORALMedication ManagementBrief manual based therapy; four 15 minute session over 10 weeks.
BEHAVIORALMayo CounselingManual based therapy; Weekly 30 minute sessions for 10 weeks
DRUGplacebo patchplacebo patch containing no nicotine
DRUGplacebo bupropionplacebo pills

Timeline

Start date
2003-09-01
Primary completion
2008-04-01
Completion
2009-06-01
First posted
2004-07-07
Last updated
2019-08-06
Results posted
2014-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00086411. Inclusion in this directory is not an endorsement.